Furthermore, MS and obesity have also been linked to higher concentrations of prothrombogenic or fibrinolysis biomarkers for instance tissue plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1). This evidence concerns the gene SERPINE1 and myeloid sarcoma.